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Background: The addition of an intra-aortic balloon pump (IABP) during peripheral venoarterial extracorporeal
membrane oxygenation (VA ECMO) support has been shown to improve coronary bypass graft flows and cardiac
function in refractory cardiogenic shock after cardiac surgery. The purpose of this study was to evaluate the impact
of additional IABP support on the cerebral blood flow (CBF) in patients with peripheral VA ECMO following
cardiac procedures.
Methods: Twelve patients (mean age 60.40 ± 9.80 years) received VA ECMO combined with IABP support for
postcardiotomy cardiogenic shock after coronary artery bypass grafting. The mean CBF in the bilateral middle
cerebral arteries was measured with and without IABP counterpulsation by transcranial Doppler. The patients
provided their control values. The mean CBF data were divided into two groups (pulsatile pressure greater than
10 mmHg, P group; pulsatile pressure less than 10 mmHg, N group) based on whether the patients experienced
cardiac stun. The mean cerebral blood flow in VA ECMO (IABP turned off) alone and VA ECMO with IABP support
were compared using the paired t test.
Results: All of the patients were successfully weaned from VA ECMO, and eight patients survived to discharge.
The addition of IABP to VA ECMO did not change the mean CBF (251.47 ± 79.28 ml/min vs. 251.30 ± 79.47 ml/min,
P = 0.96). The mean CBF was higher in VA ECMO alone than in VA ECMO combined with IABP support in the N group
(257.68 ± 97.21 ml/min vs. 239.47 ± 95.60, P = 0.00). The addition of IABP to VA ECMO support increased the mean CBF
values significantly compared with VA ECMO alone (261.68 ± 82.45 ml/min vs. 244.43 ± 45.85 ml/min, P = 0.00) in the
P group.
Conclusion: These results demonstrate that an IABP significantly changes the CBF during peripheral VA ECMO,
depending on the antegrade blood flow by spontaneous cardiac function. The addition of an IABP to VA ECMO
support decreased the CBF during cardiac stun, and it increased CBF without cardiac stun.
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Venoarterial extracorporeal membrane oxygenation (VA
ECMO) is increasingly used in various clinical acute
settings such as extracorporeal cardiopulmonary resus-
citation (ECPR) or cardiogenic shock refractory to con-
ventional treatment. There is concern that VA ECMO
might change the CBF and impair cerebral autoregulation,
resulting in neurologic dysfunction [1-8]. A clinical study
demonstrated that intra-aortic balloon pump (IABP) sup-
port in patients after cardiac surgery caused a considerable
increase in the flow velocity in the middle cerebral artery
[9]. In clinical practice, the addition of an IABP during VA
ECMO support is believed to improve coronary bypass
graft flows and cardiac function in critically ill patients
[10,11]. IABP has been successfully applied as an adjunct
to VA ECMO in patients with cardiogenic shock [12].
Despite the beneficial effects on cardiac performance, the
effects of this combination on the CBF are conflicting.
One recent clinical experience paper suggested that an
IABP obstructed VA ECMO flow in the aorta in patients
on peripheral VA ECMO [13]. End-diastolic reversal of
blood flow in the cerebral arteries has been observed in
some patients with IABP [9], which likely suggests that
the flow velocity in the right middle cerebral artery did
not increase with IABP. Transcranial Doppler ultrasound
(TCD) is a noninvasive technique that allows for repeat-
able bedside assessments of the CBF velocity (CBFV)
during cardiac and vascular surgery [14]. Previous studies
showed a positive relationship between the CBF and CBFV
[15]. The effect of an IABP on the CBF during VA ECMO
support has not been examined by TCD in humans.
We hypothesized that an IABP might change the CBF
during peripheral VA ECMO in adult patients. In the
current study, we measured the blood flow of the bilateral
middle cerebral arteries with TCD and found it might be
associated with the cardiac functional state.
Materials and methods
This study was approved by the institutional ethics
committee of Beijing Anzhen Hospital, Capital Medical
University. Informed consent was obtained for each
patient. The clinical data were prospectively collected for
all of the patients undergoing VA ECMO combined with
IABP support at the Beijing Anzhen Hospital, and the data
were stored in an electronic database.
Patients
Between January 2011 and August 2012, 12 consecutive
adult patients (mean age 60.40 ± 9.80 years, ranging from
44 to 76 years; 3 females, 25%) receiving VA ECMO and
IABP support for refractory postcardiotomy cardiogenic
shock after coronary artery bypass graft were enrolled in
the study. No patients had a neurologic disease or any
cerebral vascular disorders, as confirmed by pre-operativebrain computed tomography, ultrasonography, and mag-
netic resonance imaging. The indications for VA ECMO
support included clinical criteria of postoperative refrac-
tory cardiogenic shock, signs of end-organ failure, anaer-
obic metabolism, severe metabolic acidosis, and oliguria
(urine output ≤0.5 mL/kg/h) for ≥2 h despite optimized
supportive measures such as adequate filling volumes,
the use of high-dose catecholamines (epinephrine, do-
butamine, or norepinephrine), and the insertion of an
IABP. The hemodynamic criteria were systolic arterial
pressure < 80 mm Hg, cardiac index less than 2.2 L/
min/m2, and pulmonary capillary wedge pressure of at
least 20 mm Hg. Patients over 18 years old at the time
of VA ECMO treatment were included. The patients
with a subclavian steal phenomenon or atherosclerotic
disease of the carotid arteries (either side) according to
preoperative Doppler-sonography were excluded. Figure 1
is a schematic diagram of the study protocol.
During the time of investigation, all of the patients con-
tinuously received inotropic drugs and/or vasopressors
(epinephrine, norepinephrine, enoximone, dobutamine or
dopamine) and nitroglycerine. To prevent risks, studies
were performed only in the patients who could tolerate a
brief period without IABP assistance after their circulatory
condition was stabilized with VA ECMO support. All of the
patients received midazolam for pain relief and sedation.
Intra-aortic balloon pump
For the patients presenting with refractory cardiogenic
shock who did not respond to fluid resuscitation or
vasopressor infusion, an IABP was considered. The IABP
was installed before VA ECMO support in those critically
ill patients. In all of these patients, the IABP catheter used
was a 7.5-F, 40-ml balloon Percor STAT-DL catheter
(Datascope Corp, Fairfield, NJ) connected to a Datascope
portable computerized console (Datascope), placed using
a percutaneous insertion technique via the femoral artery.
We positioned the distal tip of the balloon catheter in the
descending thoracic aorta 2 cm distal to the origin of the
left subclavian artery. The catheter position was confirmed
by a chest x-ray. Balloon inflation was trigged by the R
wave of the electrocardiogram. The balloon was inflated
just before the diastolic notch of the arterial pressure
waveform and deflated before ventricular systole. The
electrocardiogram (ECG)-triggered IABP was set to a 1:1
assist mode and 100% balloon augmentation during VA
ECMO support.
ECMO circuit and management
Despite IABP support and high dosages of inotropic drugs
(dobutamine, dopamine, and epinephrine), there was con-
stant low cardiac output. VA ECMO is often considered
if the patient remains unstable under IABP support. The
decision to initiate ECMO was made by the attending
Figure 1 Scheme showing the study protocol. N group, pulsatile pressure ≤ 10 mmHg; P group, pulsatile pressure greater than 10 mmHg.
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tending staff. The ECMO circuit consisted of a centrifugal
pump console, a Rotaflow (Maquet, Jostra, Hirrlingen,
Germany) in conjunction with a membrane oxgenator, a
Quadrox D (Maquet, Jostra) with integrated heart exchan-
ger, an oxygen/air blender, and an oximetry monitor. All
of the components were heparin coated. For all of these
patients, the ECMO cannulae (Biomedicus, Medtronic;
Minneapolis, MN, USA) were inserted through the fem-
oral artery and femoral vein via surgical cut down. We al-
ways used a small downflow cannula into the superficial
femoral artery to ensure that the arterial flow to the leg
was maintained.
To initiate VA ECMO, the flow rate in the circuit was
increased gradually over a period of several minutes to
3.5 L/min to achieve a mixed venous oxygen saturation
(SvO2) of 65% and a systolic blood pressure arterial pres-
sure of 80-100 mm Hg. With full VA ECMO support,
intravenous inotropes and vasopressors were reduced,
and a protective lung ventilation strategy was applied to
allow for optimal myocardial and pulmonary recoveries.
The fractional inspired oxygen was adjusted to maintain
a PO2 between 100 and 200 mmHg. Continuous intra-
venous heparin was administered to obtain an activated
clotting time of 180-220 s during VA ECMO support.The VA ECMO support was terminated once hemo-
dynamic stability was restored with only minimal pharma-
cologic inotropic support. The blood gas was analyzed
every 4 hours during the VA ECMO support. The routine
blood counts and blood chemistries were analyzed every
12 hours. The patients’ hematocrit values were maintained
at 30% to 50%, and platelets were transfused when the
platelet count was less than 100 × 103/mm3 during the VA
ECMO support. The cardiac function was monitored by
transthoracic echocardiography (a left ventricular ejection
fraction ≥ 40%) during the weaning process. Step-by-step
weaning was the main strategy. The VA ECMO flow rate
was reduced to 1.5 L/min over a period of several hours.
Peripheral cannulae were removed under direct vision at
the bedside with formal repair of the vessels.
Transcranial doppler ultrasound
The measurements were performed in the cardiac in-
tensive care unit (ICU) of the Beijing Anzhen Hospital.
The patients were attached to TCD (SONSRA, VIASYS,
Healthcare Cor, USA) for CBF monitoring once every
12 hours. The Transcranial Doppler monitoring of the
bilateral middle cerebral arteries was performed with
two 2.5 MHz transducers fitted on a headband. The
ultrasound probes were fixed around the patient’s head
Table 1 Hemodynamic status details of the two groups
N group P group
heart rate IABP 92.8 ± 9.6 100.0 ± 13.5
turned off IABP 95.0 ± 13.5 97.8 ± 12.3
systolic pressure (mmHg) IABP 90.8 ± 5.2 89.6 ± 5.4
turned off IABP 89.6 ± 4,9 90.1 ± 4.8
diastolic pressure (mmHg) IABP 79.1 ± 6.2 72.6 ± 5.7
turned off IABP 77.6 ± 5.3 72.6 ± 6.8
mean artery pressure (mmHg) IABP 82.6 ± 5.4 78.9 ± 5.4
turned off IABP 81.6 ± 4.6 77.8 ± 5.7
oxygen saturation (%) IABP 95.0 ± 2.6 94.7 ± 2.4
turned off IABP 94.5 ± 2.4 94.4 ± 2.9
VA ECMO flow (L/min) 3.6 ± 0.2 3.4 ± 0.4
Hct (%) 29.4 ± 4.6 29.7 ± 4.3
No statistically significant hemodynamic changes occurred between the two
groups (p > 0.05).
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The depth of insonation varied between 35 and 52 mm
until representative spectral artery flow was identified.
The Doppler ultrasound variables, including the depth,
gain, sample volume and power of the ultrasound beam,
were not changed during the study period. The CBFV was
shown in cm/sec. The CBFV Transcranial Doppler signals
were measured once every 12 hours under turned on
IABP and turned off IABP support. After 5 minutes
IABP stabilization, the CBFV was measured. The enve-
lope curves of the Doppler frequency shift and figures
were recorded digitally for a period of 30 seconds dur-
ing each measurement and stored in a microcomputer
for further off-line analysis. Using custom software, the
data were analyzed off-line to calculate the mean CBF.
The unilateral mean CBF was derived from integration
over time. The bilateral mean CBFV was calculated using
the built-in calculation program [CBFm = (left CBFm +
right CBFm)/2]. The patients provided their control
values. The CBF was affected by the cerebral perfusion
pressure, the patient’s state of alertness, the hematocrit
(Hct), the angle of insonation, and the vessel diameter
[15]. The routine monitoring indicators, including the ar-
terial blood pressure, continuous SvO2, the VA ECMO
support flow rate, the arterial blood gases, and mean
blood pressure, were kept unchanged during the entire
study periods.
Statistical analysis
The normally distributed data were reported as the mean ±
standard deviation, and the abnormally distributed data
were reported as median values with the interquartile range
(IQR; 25th and 75th quartiles). The statistical analysis was
performed on the absolute values, and each patient served
as his or her own control. The paired t test was used to
compare the mean of the parametric variables for VA
ECMO with IABP and VA ECMO alone. The statistical
analysis was performed using SPSS 19.0 software (SPSS Inc,
Chicago, IL). A value of p < 0.05 was considered statistically
significant for all of the variables.
Results
Clinical outcomes
Of the 12 patients, nine patients (75.0%) were male. The
pre-operative ejection fraction was 42.6 ± 14.2% (29.5%
to 58.8%). All of the patients received an IABP before
VA ECMO implantation. The Sequential Organ Failure
Assessment (SOFA) score was 12.2 ± 4.6. The inotropic
score was 85.2 ± 62.9 μg/kg/min. The pre-ECMO blood
gas values were: pH 7.26 ± 0.07; PaCO2 38.4 ± 8.5 mmHg;
PaO2 75.1 ± 29.8 mmHg. The mean pre-ECMO blood
lactate level was 10.9 ± 4.5 mmol/L. The peak creatinine
kinase MB form (CK-MB) value was 335.8 ± 211.3 U/L.
In these patients, the median time interval from theend of the operation to the initiation of VA ECMO was
16.5 ± 4.2 hours (range 8-25 hours).
The mean duration of VA ECMO support was 125.90 ±
42.18 hours (75 to 200 hours). All 12 adult patients could
be successfully weaned from the VA ECMO. Eight patients
were able to be discharged from the hospital. The overall
survival rate was 66.7%. The mean IABP support time was
9.6 ± 3.7 days (range 5 to 15 days). The mean length of
stay in the ICU was 13.2 ± 3.7 days (range 8-19 days). The
causes of mortality in patients after weaning from VA
ECMO support included multi-organ failure in 2 patients
(16.7%) and sepsis in 2 patients (16.7%).
Bleeding and acute renal failure were the most common
complications of the VA ECMO. Re-thoracotomy was
required in 2 patients (16.7%) for bleeding or pericardial
tamponade. Acute renal failure requiring continuous
venovenous hemofiltration occurred in 2 (16.7%) patients.
The means of the units of blood products transfused were
6.0 ± 1.4 units of packed red blood cells, 982.6 ± 129.2 ml
of fresh frozen plasma, and 2.8 ± 1.6 units of platelets.
IABP complications were not observed in our patients.
Cerebral blood flow
No statistically significant hemodynamic changes occurred
between the two groups (p > 0.05) (Table 1).
Figure 2 shows a typical middle cerebral artery blood
flow waveform obtained by transcranial Doppler ultrason-
ography with turned on IABP and turned off IABP during
VA ECMO support. One hundred and thirty pairs of data
were obtained during VA ECMO support. No statistically
significant differences for the mean CBFs were observed
from the patients between on VA ECMO alone and on
VA ECMO with IABP support (251.47 ± 79.28 ml/min vs.
251.30 ± 79.47 ml/min, P = 0.96). Considering the cardiac




Figure 2 Typical middle cerebral artery flow waveform obtained by transcranial Doppler ultrasonography during extracorporeal
membrane oxygenation. A, B, N group. C, D, P group. (A) The CBFV while IABP is turned off in severe cardiac failure. (B) The CBFV while
ECMO was combined with IABP support in severe cardiac functional failure. (C) The CBEV while IABP is turned off in spontaneous cardiac function.
(D) The CBFV while ECMO was combined with IABP support in spontaneous cardiac function.
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pressure lower than 10 mmHg, N group, n = 45) by the
pulsate pressure without IABP support. The addition of
an IABP to VA ECMO significantly decreased the mean
CBF in the N group (257.68 ± 97.21 ml/min vs. 239.47 ±
95.60 ml/min, P = 0.00). The addition of an IABP to VA
ECMO support led to a significant increase in the mean
CBF values in the P group (261.68 ± 82.45 ml/min vs.
244.43 ± 45.85 ml/min, P = 0.00) (Figure 3 and Table 2).
Discussion
VA ECMO is effective for the treatment of acute cardiac
failure, however, the neurological morbidity has become a
significant concern for many patients [16]. At one academic
medical center, combined ischemic and hemorrhagic stroke
affected 7% of the adult patients supported with ECMO
and significantly increased the odds ratio of death [17].Brain death occurred in 7% to 21% of the cases of ECMO-
treated adults in some ECMO centers [6]. In 2009, the
national Extracorporeal Life Support Organization (ELSO)
registry reported that 21% of 295 adults treated with ECPR
experienced brain death. Additionally, approximately one-
half of the survival patients showed evidence of cerebral
injury [8]. CBF reduction (inadequate perfusion) and non-
pulsate blood flow during VA ECMO might play a role in
the pathogenesis of this complication [8,9].
VA ECMO and IABP are well-established treatments in
patients suffering postcardiotomy cardiogenic shock [12].
Most clinicians ignored the critical question of brain per-
fusion during the combination of these two treatments.
There are many reports regarding the effect of IABP on
cerebral circulation [8,18-21]. The outcomes are unclear.
In a study of animal models with cardiogenic shock, when
the cardiac output was reduced by one-third and the
Figure 3 Mean CBF in the N group and the P group under ECMO
with IABP. An IABP significantly decreased the mean CBF during
non-pulsatile pressure ECMO support. An IABP significantly increased
the mean CBF during pulsatile pressure ECMO support. The results are
reported as the mean ± standard. *, p < 0.01 between the IABP support
data and the data without IABP support.
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caused a further 10% reduction in the CBF [18]. In human
studies, Gee and colleagues [19] noted an overall reduc-
tion of 11.6% in the ocular blood flow measured by ocular
pneumoplethysmography in 56 patients on IABP assist-
ance. Similarly, a reverse CBF occurring at the end of the
diastole was observed by Schachtrupp and colleagues
[9]. In a model of VA ECMO-treated cardiac arrest, the
authors tested an often encountered clinical combination
of VA ECMO with IABP. They found that when used
with the femoro-femoral VA ECMO approach, IABP
did not significantly change the CBFV [20]. A clinical
study reported that because of an early systolic reversal
blood flow, no net increase occurred in the total flow in
the common carotid artery with IABP support [21].
These results indicated that rapid deflation of the IABP
decreased the pre-ejection CBF, and cerebral perfusion
might be inadequate or unchanged. In our study, although
this type of reverse phenomenon was not observed in any
of the patients, the outcome might be dependent on the
antegrade blood flow. And this phenomenon was sup-
ported by the results from Schachtrupp and colleagues [9]
reported that IABP significantly increased the antegrade
mean flow in the middle cerebral artery in patients after
cardiac surgery.
During the peripheral VA ECMO support, the blood
ejected from the heart theoretically would perfuse the
heart, brain, and upper extremities. Taylor and colleagues
reported that the CBF was determined by the cardiacTable 2 Outcome of the CBF in the patients
Total
VA ECMO with IABP (ml/min) 251.47 ± 79.2
VA ECMO alone (turned off IABP) (ml/min) 251.30 ± 79.4
p value 0.96function by analyzing the effects of the systolic cardiac
performance on the intracranial hemodynamics in nine
infants undergoing ECMO [22]. Rosenberg and Kinsella,
using the radioactive microsphere method, showed that
the CBF velocity was decreased in newborn lambs after
the initiation of VA ECMO support at low flow rates.
Higher flow rates could stabilize cerebral hemodynamics
[23]. These findings suggested that CBF is dependent on
cardiac output or the intensity of the ECMO support.
IABP was employed in most of the VA ECMO setups
with the aim of reducing the after load to improve the
coronary perfusion and maintain a pulsatile blood flow.
Previous studies have suggested an improved clinical
outcome of VA ECMO support combined with IABP in
patients with cardiogenic shock [12]. There are concerns
that an intermittent aortic occlusion by the IABP balloon
might diminish the available cerebral blood [13]. No studies
have reported the cerebral flow during the concomitant
support of VA ECMO and IABP in adults by TCD, as was
done in this study. We found that the mean CBF was sig-
nificantly lower in VA ECMO combined with IABP support
than in VA ECMO alone during myocardial stunning (a
pulsate pressure lower than 10 mmHg) when there was
slight antegrade flow ejected by the heart. We found that
the CBF values were significantly higher in VA ECMO
combined with IABP than with VA ECMO alone during
the spontaneous cardiac function period (Figure 2). The
effect of IABP on CBF during VA ECMO support appears
to vary with the spontaneous cardiac function state.
No significant differences in our study were found in
the response of the mean CBFs during the combination
support and VA ECMO. The authors commented as to
the specific condition between the statement of the
spontaneous cardiac and that of the VA ECMO and
IABP support. The effect of IABP on the CBF might be
different for severe cardiac failure and spontaneous car-
diac function during VA ECMO support. When the data
were analyzed between the different cardiac functional
states, the data of the mean CBF were divided into two
groups (P group and N group) by the cardiac function
state (determined with pulsate pressure after turning off
IABP during the VA ECMO support). These results
demonstrated that in a severe cardiac dysfunction situ-
ation (a pulsate pressure lower than 10 mmHg), IABP
might have an unfavorable effect on CBF during the per-
ipheral VA ECMO support. The implementation of IABP
during the early stage of the ECMO support resulted inN group P group
8 239.47 ± 95.60 261.68 ± 82.45
7 257.68 ± 97.21 244.43 ± 45.85
0.00 0.00
Yang et al. Journal of Translational Medicine 2014, 12:106 Page 7 of 8
http://www.translational-medicine.com/content/12/1/106a significant decrease of the CBF. Clinically, some pa-
tients had essentially no ventricular cardiac output with
‘ventricular stun’ during VA ECMO support. The pulse
pressure of the pericallosal artery is frequently lower
than 10 mmHg [24]. The TCD ultrasonogram of the
cerebral blood velocity tracing showed a flat waveform, as
shown in Figure 2A. Under such conditions, VA ECMO
provided retrograde blood flow from descending to
ascending across the IABP. The diastolic inflation of the
intra-aortic balloon might intermittently compromise the
retrograde non-pulsatile ECMO flow to the brain during
the concomitant use of ECMO and IABP. This finding
might explain the reason that IABP in late diastole caused
a drop in the CBFV during severe cardiac failure. The
recovery of the heart results from the appearance of the
antegrade aortic flow during VA ECMO support. The
addition of IABP significantly increased the mean CBF
under such conditions. Additionally, the use of an IABP to
maintain pulsatility during VA ECMO support is uniformly
agreed upon in some studies [11,13]. The pulsatility effect
of IABP probably led to improved CBF perfusion and
contributes to cerebral autoregulation recovery.
There are several limitations in our study. First, given
the emergent setting, we lacked a neurological evaluation
and CBF measurement performed prior to a trial of VA
ECMO. Second, the state of the global and regional
cerebral arteries was not examined in this study. Third,
we did not study the long-term effects of the IABP and
VA ECMO combination in our patients. The relation-
ships between the CBF change and the neurological
outcome of VA ECMO in adults are unknown.
Conclusion
IABP significantly changed the CBF during peripheral
VA ECMO, depending on the antegrade blood flow by
spontaneous cardiac function. Our study showed that
IABP significantly decreased the mean of the CBF during
myocardial stunning, but increasing the mean of the CBF
during the recovery of cardiac function.
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